Cargando…

JDP2, a Novel Molecular Key in Heart Failure and Atrial Fibrillation?

Heart failure (HF) and atrial fibrillation (AF) are two major life-threatening diseases worldwide. Causes and mechanisms are incompletely understood, yet current therapies are unable to stop disease progression. In this review, we focus on the contribution of the transcriptional modulator, Jun dimer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Euler, Gerhild, Kockskämper, Jens, Schulz, Rainer, Parahuleva, Mariana S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074072/ https://www.ncbi.nlm.nih.gov/pubmed/33923401 http://dx.doi.org/10.3390/ijms22084110

Ejemplares similares

Structural, Pro-Inflammatory and Calcium Handling Remodeling Underlies Spontaneous Onset of Paroxysmal Atrial Fibrillation in JDP2-Overexpressing Mice
por: Parahuleva, Mariana S., et al.
Publicado: (2020)

JDP2 overexpression provokes cardiac dysfunction in mice
por: Heger, Jacqueline, et al.
Publicado: (2018)

Incidence of Atrial Fibrillation in Postmenopausal Women with Endometrial Cancer
por: Parahuleva, Mariana S., et al.
Publicado: (2021)

Publisher Correction: Identification of microRNAs as potential cellular monocytic biomarkers in the early phase of myocardial infarction: a pilot study
por: Parahuleva, Mariana S., et al.
Publicado: (2018)

MicroRNA expression profile of human advanced coronary atherosclerotic plaques
por: Parahuleva, Mariana S., et al.
Publicado: (2018)

Identification of microRNAs as potential cellular monocytic biomarkers in the early phase of myocardial infarction: a pilot study
por: Parahuleva, Mariana S., et al.
Publicado: (2017)

Atrial Fibrillation and Heart Failure
por: Bergau, Leonard, et al.
Publicado: (2022)

Catheter ablation of atrial fibrillation—A key role in heart failure therapy?
por: Tose Costa Paiva, Beatriz, et al.
Publicado: (2019)

Left Atrial Myocardium in Arterial Hypertension
por: Kockskämper, Jens, et al.
Publicado: (2022)

New-Onset Atrial Fibrillation in the Setting of COVID-19 Infection Is a Predictor of Mortality in Hospitalized Patients: CovAF-Study
por: Parahuleva, Mariana S., et al.
Publicado: (2023)

Atrial fibrillation ablation in heart failure
por: Balla, Cristina, et al.
Publicado: (2020)

Atrial Fibrillation in Heart Failure: An Innocent Bystander?
por: Khan, MA, et al.
Publicado: (2012)

Editorial Genomics of Atrial Fibrillation and Heart Failure
por: Xiao, Junjie
Publicado: (2015)

Atrial Electrophysiological Remodeling and Fibrillation in Heart Failure
por: Pandit, Sandeep V., et al.
Publicado: (2016)

Role of Monocytes in Heart Failure and Atrial Fibrillation
por: Shahid, Farhan, et al.
Publicado: (2018)

Calcium in the Pathophysiology of Atrial Fibrillation and Heart Failure
por: Denham, Nathan C., et al.
Publicado: (2018)

Atrial Fibrillation Ablation in Heart Failure Patients
por: Derndorfer, Michael, et al.
Publicado: (2021)

Interaction Between Heart Failure and Atrial Fibrillation
por: Kim, Yun Gi
Publicado: (2022)

Atrial fibrillation in heart failure: drugs or ablation?
por: Palmas, Francesco, et al.
Publicado: (2023)

Hsp40/JDP Requirements for the Propagation of Synthetic Yeast Prions
por: Miller, Sarah C., et al.
Publicado: (2022)

TRE-dependent transcription activation by JDP2–CHOP10 association
por: Weidenfeld-Baranboim, Keren, et al.
Publicado: (2008)

Host JDP2 expression in the bone marrow contributes to metastatic spread
por: Barbarov, Yelena, et al.
Publicado: (2015)

The AP-1 repressor protein, JDP2, potentiates hepatocellular carcinoma in mice
por: Bitton-Worms, Keren, et al.
Publicado: (2010)

Endoglin integrates BMP and Wnt signalling to induce haematopoiesis through JDP2
por: Baik, June, et al.
Publicado: (2016)

Opposing effects of KDM6A and JDP2 on glucocorticoid sensitivity in T-ALL
por: Levinson, Anya L., et al.
Publicado: (2023)

Advances in the management of atrial fibrillation in congestive heart failure
por: Gopinathannair, Rakesh, et al.
Publicado: (2009)

Catheter Ablation for Atrial Fibrillation in Patients with Heart Failure
por: Scanavacca, Mauricio, et al.
Publicado: (2018)

The impact of catheter ablation for atrial fibrillation in heart failure
por: Moschonas, Konstantinos, et al.
Publicado: (2018)

Risk Factors of Atrial Fibrillation in Patients with Heart Failure
por: Sarfraz, Alam, et al.
Publicado: (2018)

Genetic risk and atrial fibrillation in patients with heart failure
por: Kloosterman, Mariëlle, et al.
Publicado: (2020)

Rhythm Control in Heart Failure Patients with Atrial Fibrillation
por: Eysenck, William, et al.
Publicado: (2020)

Digoxin Impact on Heart Failure Patients with Atrial Fibrillation
por: Gerakaris, Andreas, et al.
Publicado: (2022)

Improving the diagnosis of heart failure in patients with atrial fibrillation
por: Bunting, Karina V, et al.
Publicado: (2021)

Atrial fibrillation in heart failure: Prime time for ablation!
por: Deisenhofer, Isabel
Publicado: (2021)

Incidence and Predictors of Heart Failure in Patients With Atrial Fibrillation
por: Krisai, Philipp, et al.
Publicado: (2021)

Pathophysiological pathways in patients with heart failure and atrial fibrillation( )
por: Santema, Bernadet T, et al.
Publicado: (2021)

Atrial fibrillation and heart failure temporality: does it matter?
por: Van Deutekom, Colinda, et al.
Publicado: (2022)

Endothelial Mesenchymal Transition in Hypoxic Microvascular Endothelial Cells and Paracrine Induction of Cardiomyocyte Apoptosis Are Mediated via TGFβ(1)/SMAD Signaling
por: Sniegon, Isabella, et al.
Publicado: (2017)

Factor VII Activating Protease Expression in Human Platelets and Accumulation in Symptomatic Carotid Plaque
por: Parahuleva, Mariana S., et al.
Publicado: (2020)

JDP2: An oncogenic bZIP transcription factor in T cell acute lymphoblastic leukemia
por: Mansour, Marc R., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_dmjh763f27r2s32vunsqkb95av